By Kim Richters

Bayer AG said Thursday it has agreed to resolve the legal claims in the U.S. related to its Essure birth control device, paying around $1.6 billion.

The German pharmaceutical and chemical company said it had so far reached agreements with plaintiff law firms for around 90% of the almost 39,000 filed and unfiled U.S. Essure claims, which involve women who allege device-related injuries.

Bayer said it had provisioned for the settlement, which includes "an allowance for outstanding claims," and that it "is in resolution discussions with counsel for the remaining plaintiffs."

The settlement doesn't have any effect on pending litigation in other countries and there "is no admission of wrongdoing or liability by Bayer in the settlement agreements," the company said.

Write to Kim Richters at kim.richters@wsj.com

(END) Dow Jones Newswires

August 20, 2020 13:48 ET (17:48 GMT)

Copyright (c) 2020 Dow Jones & Company, Inc.
Bayer (TG:BAYN)
Historical Stock Chart
Von Mär 2024 bis Apr 2024 Click Here for more Bayer Charts.
Bayer (TG:BAYN)
Historical Stock Chart
Von Apr 2023 bis Apr 2024 Click Here for more Bayer Charts.